Medical Patent News

RSS

LFB receives U.S. patent titled 'Monoclonal Antibodies with Enhanced ADCC Function'

LFB announced today that it has been recently issued U.S. Patent 7,931,895 titled "Monoclonal Antibodies with Enhanced ADCC Function" on April 26, 2011, by the U.S. Patent and Trademark Office.

8 Jul 2011

U.S. District Court rules in favor of Watson over Mucinex patent suit

Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R), Mucinex(R) D, and Mucinex(R) DM Extended-Release products do not infringe U.S. Patent No. 6,372,252.

8 Jul 2011

USPTO awards patent for key therapeutic ingredient in CNVN202 targeted molecular cancer therapy

Convergen LifeSciences, Inc. announced today that a United States Patent has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and Human Services.

29 Jun 2011

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

24 Jun 2011

Pharmasset receives U.S. patent titled 'Nucleoside Phosphoramidate Prodrugs'

Pharmasset, Inc. announces that the United States Patent and Trademark Office has issued U.S. patent 7,964,580 titled "Nucleoside Phosphoramidate Prodrugs".

22 Jun 2011

Supreme Court accepts case that could shape field of personalized medicine

The U.S. Supreme Court, accepting a case that will shape the burgeoning business of personalized medicine, agreed to consider what types of diagnostic medical tests can be patented. The justices agreed today to hear an appeal from the Mayo Clinic, which is challenging a lower court decision backing two patents for determining the dosage of medicines to treat stomach diseases.

22 Jun 2011

Two NJIT researchers receive U.S. Patent for nanoprobe array technique

Reginald C. Farrow and Zafer Iqbal, research professors at NJIT, were awarded a patent today for an improved method of fabricating arrays of nanoscale electrical probes. Their discovery may lead to improved diagnostic tools for measuring the spatial variation of electrical activity inside biological cells.

22 Jun 2011

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a U.S. patent relating to a technology for the treatment of cancer for which the Company holds an exclusive, worldwide license.

22 Jun 2011

Palatin receives U.S. patent titled ‘Amino Acid Surrogates for Peptidic Constructs'

Palatin Technologies, Inc. announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 7,964,181, titled "Amino Acid Surrogates for Peptidic Constructs."

22 Jun 2011

AusBiotech supports ‘Raising the Bar’

AusBiotech welcomes a legislative Bill that has been introduced into the Australian Parliament today - The Intellectual Property Laws Amendment (Raising the Bar) Bill 2011.

21 Jun 2011

European Patent Office issues notice of allowance to Kuros' synthetic biomaterials

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today the allowance of European Patent Application 00910049 by the European Patent Office.

20 Jun 2011

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that the United States District Court for the District of Nevada denied Duramed Pharmaceuticals, Inc.'s request for a preliminary injunction and request for a temporary restraining order preventing Watson's launch of generic SEASONIQUE and ethinyl estradiol.

18 Jun 2011

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Predictive Biosciences, a provider of novel molecular diagnostic tests, announced that on June 7, 2011 the U.S. Patent and Trademark Office issued Patent Number 7,955,822 for "Detection of Nucleic Acids and Proteins".

17 Jun 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.

16 Jun 2011

USPTO upholds ten amended claims of SANUWAVE's '119 patent

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.

15 Jun 2011

Medical Patent News

LFB receives U.S. patent titled 'Monoclonal Antibodies with Enhanced ADCC Function'

U.S. District Court rules in favor of Watson over Mucinex patent suit

USPTO awards patent for key therapeutic ingredient in CNVN202 targeted molecular cancer therapy

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Pharmasset receives U.S. patent titled 'Nucleoside Phosphoramidate Prodrugs'

Supreme Court accepts case that could shape field of personalized medicine

Two NJIT researchers receive U.S. Patent for nanoprobe array technique

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

Palatin receives U.S. patent titled ‘Amino Acid Surrogates for Peptidic Constructs'

AusBiotech supports ‘Raising the Bar’

European Patent Office issues notice of allowance to Kuros' synthetic biomaterials

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

USPTO upholds ten amended claims of SANUWAVE's '119 patent

Galectin strengthens cancer drug patent portfolio in Europe

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

AJ, ATCC sign worldwide non-exclusive licensing agreement for iPS cell patent portfolio

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News